Search results
Results From The WOW.Com Content Network
Penicillin-allergic women without a history of anaphylaxis (angioedema, respiratory distress, or urticaria) following administration of a penicillin or a cephalosporin (low risk of anaphylaxis) could receive cefazolin (2 g IV initial dose, then 1 g IV every 8 hours until delivery) instead of penicillin or ampicillin.
Cefazolin, also known as cefazoline and cephazolin, is a first-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. [2] Specifically it is used to treat cellulitis , urinary tract infections , pneumonia , endocarditis , joint infection , and biliary tract infections . [ 2 ]
In pharmacokinetics, the rate of infusion (or dosing rate) refers not just to the rate at which a drug is administered, but the desired rate at which a drug should be administered to achieve a steady state of a fixed dose which has been demonstrated to be therapeutically effective. Abbreviations include K in, [1] K 0, [2] or R 0.
The overall discontinuation rate for ceftaroline-treated subjects was 2.7% compared to a rate of 3.7% for the comparator group-treated subjects. The most common adverse reactions occurring in > 2% of subjects receiving ceftaroline in the pooled phase-III clinical trials were diarrhea, nausea, and rash.: [18]
The solution of this differential equation is useful in calculating the concentration after the administration of a single dose of drug via IV bolus injection: = C t is concentration after time t; C 0 is the initial concentration (t=0) K is the elimination rate constant
Cefoxitin is sold in three major IV doses, 1g, 2g, and 10g. [21] It is usually given to adults every six to eight hours in 1g or 2g doses. [22] Cefoxitin may interfere with tests detecting urine glucose and result in a false positive. [23] As with any antibiotic, it should not be given to patients who are allergic to it. [23]
The United Kingdom's Health Protection Agency has stated that "most isolates with NDM-1 enzyme are resistant to all standard intravenous antibiotics for treatment of severe infections." [ 100 ] On 26 May 2016, an E. coli " superbug " was identified in the United States resistant to colistin , "the last line of defence" antibiotic .
It works similarly to other agents within this class, including intravenous cefazolin, but can be taken by mouth. [5] Cefalexin can treat certain bacterial infections, including those of the middle ear, bone and joint, skin, and urinary tract. [4] It may also be used for certain types of pneumonia and strep throat and to prevent bacterial ...